Featured Content
Latest Press Releases
- Jun 24, 2022 New Analysis Finds UPLIZNA® (inebilizumab) Effective Among European Populations with Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Jun 15, 2022 Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA® (inebilizumab) in Brazil
- Jun 15, 2022 Horizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago™
Statements
Named Patient Use Programs
Featured Videos
Corporate Brochure
Corporate Brochure
Fact Sheets & Downloads
Logo Download
Horizon Logo | Full Color
Horizon Logo | Full Color, White Text
Horizon Logo | White
Horizon Logo | Charcoal
If you are looking for additional Horizon media assets, please contact corpcomms@horizontherapeutics.com.
Media Inquiries
For U.S. media inquiries, contact:
Geoff Curtis
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com
+1 (888) 506-2562
For EU media inquiries, contact:
Ray Gordon
Managing Director
ray@gordonmrm.ie
+353 (87) 2417373